These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26707323)

  • 1. Race, Calcineurin Inhibitor Exposure, and Renal Function After Solid Organ Transplantation.
    Yessayan L; Shafiq A; Peterson E; Wells K; Hu Y; Williams LK; Lanfear D
    Transplant Proc; 2015 Dec; 47(10):2968-72. PubMed ID: 26707323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.
    Karie-Guigues S; Janus N; Saliba F; Dumortier J; Duvoux C; Calmus Y; Lorho R; Deray G; Launay-Vacher V; Pageaux GP
    Liver Transpl; 2009 Sep; 15(9):1083-91. PubMed ID: 19718632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin-inhibitor minimization in liver transplant patients with calcineurin-inhibitor-related renal dysfunction: a meta-analysis.
    Kong Y; Wang D; Shang Y; Liang W; Ling X; Guo Z; He X
    PLoS One; 2011; 6(9):e24387. PubMed ID: 21931704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
    Weir MR; Pearson TC; Patel A; Peddi VR; Kalil R; Scandling J; Chan L; Baliga P; Melton L; Mulgaonkar S; Waid T; Schaefer H; Youssef N; Anandagoda L; McCollum D; Lawson S; Gordon R
    Transplantation; 2017 Jan; 101(1):157-165. PubMed ID: 26950714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Function Changes Under Everolimus Plus Cyclosporine or Everolimus Plus Tacrolimus After Heart Transplantation.
    Chiang TY; Tsao CI; Wang SS
    Transplant Proc; 2018 Nov; 50(9):2756-2758. PubMed ID: 30401391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term glomerular filtration rate in liver allograft recipients according to the type of calcineurin inhibitors.
    Niel OR; Berthoux F; Albano L; Dahan P; Aoudia R; Gugenheim J; Cassuto E
    Transplant Proc; 2009 Oct; 41(8):3329-32. PubMed ID: 19857743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity.
    Ziolkowski J; Paczek L; Senatorski G; Niewczas M; Oldakowska-Jedynak U; Wyzgal J; Sanko-Resmer J; Pilecki T; Zieniewicz K; Nyckowski P; Patkowski W; Krawczyk M
    Transplant Proc; 2003 Sep; 35(6):2307-9. PubMed ID: 14529923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of maintenance immunosuppression medication on the change in kidney allograft function.
    Gill JS; Tonelli M; Mix CH; Johnson N; Pereira BJ
    Kidney Int; 2004 Feb; 65(2):692-9. PubMed ID: 14717943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
    Nankivell BJ; PʼNg CH; OʼConnell PJ; Chapman JR
    Transplantation; 2016 Aug; 100(8):1723-31. PubMed ID: 27306529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.
    Helmschrott M; Rivinius R; Bruckner T; Katus HA; Doesch AO
    Drug Des Devel Ther; 2017; 11():1673-1680. PubMed ID: 28652705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of renal function following orthotopic heart transplant.
    Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
    Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial comparing late concentration-controlled calcineurin inhibitor or mycophenolate mofetil withdrawal.
    Mourer JS; Hartigh Jd; van Zwet EW; Mallat MJ; Dubbeld J; de Fijter JW
    Transplantation; 2012 May; 93(9):887-94. PubMed ID: 22538450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients.
    Kaplinsky E; González-Costello J; Manito N; Roca J; Barbosa MJ; Nebot M; Salazar-Mendiguchia J; Berdejo J; Mañas P; Miralles A; Cequier A
    Transplant Proc; 2012 Nov; 44(9):2564-6. PubMed ID: 23146455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment.
    Baran DA; Galin ID; Gass AL
    Am J Cardiovasc Drugs; 2004; 4(1):21-9. PubMed ID: 14967063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.
    Jacquet A; Francois H; Frangie C; Ahmad L; Charpentier B; Durrbach A
    Transpl Immunol; 2008 Nov; 20(1-2):29-31. PubMed ID: 18817870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study.
    Rodrigues N; Santana A; Guerra J; Neves M; Nascimento C; Gonçalves J; da Costa AG
    Transplant Proc; 2017 May; 49(4):799-802. PubMed ID: 28457398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.